Financial firms are spending billions on increasingly onerous compliance rules each year. Themis offers pay-as-you-go risk-management and compliance for banks, fintechs and crypto startups. See the ...
PARIS — For patients with type 2 diabetes and stable coronary artery disease, the benefits of adding ticagrelor (Brilinta/Brilique, AstraZeneca) to aspirin in terms of reduced ischemic events did not ...
Merck has struck a deal to work with Themis Bioscience on vaccine R&D. The agreement sees Merck invest in Themis and commit up to $200 million (€180 million) in milestones to secure vaccines against ...
Themis is a purpose-built collaboration tech platform designed for banks, fintechs, and crypto NEW YORK, NY / ACCESSWIRE / April 19, 2022 / Themis, a collaborative governance, risk, and compliance ...
Themis has raised €40 million ($44 million). The Merck-backed series D positions Themis to take its chikungunya vaccine through a phase 3 trial and move the lead candidate from its immuno-oncology R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results